Phase I Study of Vandetanib During and After Radiotherapy in Children With Diffuse Intrinsic Pontine Glioma - Concepedia

Concepedia

Publication | Open Access

Phase I Study of Vandetanib During and After Radiotherapy in Children With Diffuse Intrinsic Pontine Glioma

DOI Full Paper Access

122

Citations

28

References

2010

Year

Alberto Broniscer, Justin N. Baker, Michael Tagen, Arzu Onar‐Thomas, Richard J. Gilbertson, Andrew M. Davidoff, Atmaram Pai Panandiker, Wing Leung, Thomas K. Chin, Clinton F. Stewart,

Journal of Clinical Oncology

Abstract

The recommended phase II dose of vandetanib in children is 145 mg/m(2) per day. Close monitoring and management of hypertension is required, particularly for patients receiving corticosteroids.

References

	Year	Citations

Page 1